sofosbuvir/velpatasvir — Medica
Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 3, 4, 5, or 6, no cirrhosis or compensated cirrhosis (Child-Pugh A)
Initial criteria
- age ≥ 3 years
- Patient does not have cirrhosis OR has compensated cirrhosis (Child-Pugh A)
- Patient has not been previously treated with sofosbuvir/velpatasvir
- Prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or liver transplant physician
Approval duration
12 weeks